Talazoparib + Enzalutamide Beneficial in Metastatic Prostate Cancer
Improvement seen in median imaging-based progression-free survival, regardless of homologous recombination repair status
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.